What are the causes, clinical presentation, diagnostic work‑up, and management strategies for acute pericarditis, pericardial effusion (including cardiac tamponade), and chronic constrictive pericarditis?

Pericardial Diseases: Comprehensive Management Framework

Acute Pericarditis

Clinical Presentation and Diagnosis

Acute pericarditis presents with a classic triad: sharp, pleuritic chest pain (often relieved by sitting forward), pericardial friction rub (best heard at end-expiration with patient leaning forward), and characteristic ECG changes showing diffuse ST-segment elevation with PR-segment depression. 1

• The pericardial friction rub is highly specific but frequently absent or transient, so its absence does not exclude the diagnosis 1, 2
• ECG findings evolve through stages: initial widespread ST elevation with PR depression, followed by normalization, then T-wave inversion 2
• Echocardiography should be performed in all suspected cases to assess for effusion and exclude tamponade 1

Etiologic Considerations by Geographic Context

In developed countries, viral infections account for the majority of cases (42-49%), though up to 50% remain idiopathic despite thorough workup; in developing countries, tuberculosis causes over 60% of cases, particularly in HIV-endemic regions. 3, 4

• Common viral pathogens include enteroviruses, echoviruses, adenoviruses, cytomegalovirus, and Epstein-Barr virus 3
• Post-cardiac surgery pericarditis accounts for 11-37% of cases in developed countries 4
• Radiation-induced pericarditis occurs in 9-31% of patients treated for Hodgkin's disease or breast cancer 4
• Autoimmune causes include systemic lupus erythematosus, rheumatoid arthritis, and scleroderma 3, 4
• Drug-induced pericarditis can result from procainamide, hydralazine, methyldopa, anthracyclines, and dasatinib 1, 3

First-Line Treatment Strategy

NSAIDs combined with colchicine represent the optimal first-line therapy for acute pericarditis, with aspirin substituted for NSAIDs in post-myocardial infarction cases. 5, 2

• Colchicine should be initiated concomitantly with NSAIDs in all cases, particularly for severely symptomatic patients, as it hastens symptom resolution and reduces recurrence risk 5, 2
• Aspirin (750-1000 mg every 8 hours) is preferred over NSAIDs when pericarditis complicates acute myocardial infarction 5
• Treatment duration should be at least 3 months to prevent recurrence 1

Corticosteroid Use: Critical Caveats

Systemic corticosteroids should generally be avoided in acute pericarditis due to significantly higher recurrence rates, reserved only for refractory cases unresponsive to NSAIDs plus colchicine, or for specific immune-mediated etiologies. 1, 5

• When corticosteroids are necessary, use prednisone 1-2 mg/kg/day initially, maintain for 5-7 days, then taper over 3 months 1
• Toward the end of the taper, reintroduce NSAIDs or colchicine and continue for at least 3 months 1
• In tuberculous pericarditis, corticosteroids are contraindicated except as adjunct to antituberculous therapy in HIV-negative patients, where they reduce constrictive pericarditis incidence by 46% 1, 6
• Critical pitfall: Corticosteroids are absolutely contraindicated in HIV-positive tuberculous pericarditis due to increased risk of HIV-associated malignancies 6

Recurrent Pericarditis Management

Colchicine should be used as initial therapy for all recurrences and in all refractory cases resistant to standard NSAID therapy. 5

• Pericardiectomy is indicated only for frequent, highly symptomatic recurrences resistant to all medical therapy (Class IIa indication) 1
• Before pericardiectomy, patients must be on a steroid-free regimen for several weeks 1
• Post-pericardiectomy recurrences can occur, possibly due to incomplete pericardial resection 1

---

Pericardial Effusion and Cardiac Tamponade

Diagnostic Approach Based on Clinical Context

When inflammatory signs (fever, friction rub, ECG changes) accompany pericardial effusion, manage as acute pericarditis; cardiac tamponade without inflammatory signs carries higher risk of malignant etiology; severe effusion without tamponade or inflammation is usually chronic idiopathic. 3

• Echocardiography is the primary diagnostic tool for detecting and quantifying pericardial effusion 1, 7
• Large effusions (≥2 cm) are common with neoplastic, tuberculous, uremic, and hypothyroid causes 1
• Slowly accumulating effusions can be remarkably asymptomatic even when large, while rapidly accumulating smaller volumes present with tamponade 1

Echocardiographic Features of Cardiac Tamponade

Cardiac tamponade is diagnosed by the combination of clinical signs (hypotension, tachycardia, pulsus paradoxus) and echocardiographic findings including diastolic right ventricular collapse, late diastolic right atrial collapse, increased mitral inflow with expiration, IVC plethora, and abnormal ventricular septal motion. 1

• Diastolic right ventricular compression and late diastolic right atrial collapse are highly specific findings 1
• Respiratory variation of mitral inflow velocities exceeding 25% supports the diagnosis 1
• Critical pitfall: In uremic patients, heart rate may remain inappropriately slow (60-80 bpm) during tamponade due to autonomic impairment, despite fever and hypotension 1

Indications for Pericardiocentesis

Emergency pericardiocentesis should be performed promptly when cardiac tamponade is suspected; elective pericardiocentesis is indicated for large effusions (≥2 cm) or for diagnostic purposes when etiology is unclear. 1

• Pericardiocentesis is not necessary when the diagnosis can be made otherwise or when effusions are small or resolving under anti-inflammatory treatment 1
• Patients with dehydration and hypovolemia may temporarily improve with intravenous fluids before drainage 1
• After pericardiocentesis, the drain should remain in place for 3-5 days to prevent acute recurrence 1, 5

Pericardial Fluid Analysis

All pericardial fluid should be sent for chemistry, microbiology (including at least three cultures for bacterial causes), and cytology. 1

• Malignant effusions with negative cytology on early pericardiocentesis usually become positive over time 1
• PCR techniques have much higher sensitivity and specificity for viral diagnosis compared to viral culture 1
• Immunohistochemistry (IgG, IgM, IgA, complement fixation) on pericardial/epicardial biopsies significantly enhances diagnostic yield 1

Management of Recurrent or Refractory Effusions

If drainage output remains high 6-7 days after pericardiocentesis, surgical pericardial window should be considered; effusions are more likely to recur with percutaneous pericardiocentesis compared to pericardiotomy. 1

• For malignant effusions, factors predicting poorer 2-year survival include age >65 years, platelet count <20,000, lung cancer, presence of malignant cells in effusion, and prolonged drainage duration 1
• Intrapericardial cisplatin achieves freedom from hemodynamically significant recurrence in 93% at 3 months and 83% at 6 months for malignant effusions 1
• Resistant neoplastic effusions require percutaneous balloon pericardiotomy or rarely pericardiectomy 1

Special Etiologies Requiring Specific Management

Tuberculous pericarditis requires rifampicin-based antituberculous therapy for 6 months, which reduces progression to constriction from >80% to <10%; adjunctive prednisolone in HIV-negative patients reduces constrictive pericarditis incidence by 46%. 1, 6

• Prednisone should be administered at 1-2 mg/kg/day since rifampicin induces hepatic metabolism, maintained for 5-7 days, then tapered over 6-8 weeks 1
• Mortality in untreated acute effusive tuberculous pericarditis approaches 85% 1
• Pericardial constriction occurs in 30-50% of untreated tuberculous cases 1

Uremic pericarditis (BUN >60 mg/dL) requires intensive dialysis; dialysis-associated pericarditis results from inadequate dialysis or fluid overload. 1

• ECG typically does not show the diffuse ST/T wave elevations seen in other causes due to lack of myocardial inflammation 1
• Pericardial rubs may persist even with large effusions or may be transient 1

Hypothyroidism causes pericardial effusion in 5-30% of patients; effusions may be quite large but tamponade occurs rarely. 1, 3

• Diagnosis is confirmed by elevated TSH level 1
• Clinical features include relative bradycardia and low QRS voltage on ECG 1

Anticoagulation Considerations

Anticoagulation with heparin or warfarin is not associated with increased risk of cardiac tamponade in acute pericarditis or myopericarditis; however, in iatrogenic pericardial effusion, full anticoagulation may increase tamponade risk. 1

---

Chronic Constrictive Pericarditis

Diagnostic Imaging Algorithm

Transthoracic echocardiography is the first-line imaging test for suspected constrictive pericarditis, specifically assessing for septal bounce, respiratory variation of mitral peak E velocity >25%, and ventricular interdependence. 6

• Chest radiography (frontal and lateral views) should be obtained to identify pericardial calcifications, though these are absent in up to 20% of cases 6
• CT and/or cardiac MRI are recommended as second-line imaging to measure pericardial thickness (normal <3 mm), detect calcifications, evaluate inflammatory activity via contrast enhancement, and define anatomic extent 6
• Critical diagnostic pearl: Normal pericardial thickness does not rule out constrictive pericarditis; 18-20% of surgically confirmed cases have thickness <3 mm 1, 6

Key Echocardiographic Diagnostic Features

Specific echocardiographic criteria include septal bounce, respiratory variation of mitral peak E velocity >25%, E/A ratio >2 with short deceleration time, and lateral e′ >8 cm/s on tissue Doppler (which helps differentiate from restrictive cardiomyopathy). 6

• Dilated inferior vena cava and hepatic veins with limited respiratory fluctuation are additional supportive findings 6
• Increased mitral inflow with expiration is characteristic 1

Hemodynamic Assessment

Cardiac catheterization should be performed when non-invasive studies are inconclusive, looking for "dip-and-plateau" (square-root) pattern in ventricular pressure curves and equalization of left and right ventricular end-diastolic pressures within 5 mmHg. 6

• During pericardiocentesis, intrapericardial and right-heart pressures must be monitored 6
• Effusive-constrictive pericarditis is diagnosed when right atrial pressure fails to fall by ≥50% or remains >10 mmHg after fluid drainage 6

Etiologic Considerations

Tuberculosis, mediastinal irradiation, and previous cardiac surgery are the most frequent causes of constrictive pericarditis. 1

• Radiation-induced constrictive pericarditis has worse surgical outcomes than other causes due to coexisting myopathy and valvular involvement 1, 6
• Constriction can develop in 18% of patients with normal pericardial thickness 1
• Transient constrictive pericarditis is an important entity that resolves with medical therapy and does not require pericardiectomy 1

Risk Stratification: Transient vs. Chronic Constriction

Features indicating chronic (surgical) disease include cachexia, atrial fibrillation, hepatic dysfunction, pericardial calcification on imaging, and prolonged symptom duration; features suggesting potentially reversible (transient) constriction include elevated CRP, pericardial contrast enhancement on CT/CMR, recent onset pericarditis with mild effusion, and hemodynamic stability. 6

Treatment Algorithm

A 2-3 month trial of anti-inflammatory therapy (NSAIDs, colchicine, or glucocorticoids when inflammation is evident) is recommended before considering pericardiectomy in hemodynamically stable patients without chronic disease features. 6

• Loop diuretics should be used to control volume overload and peripheral edema during the conservative phase 6
• Serial CT or CMR surveillance is advised to monitor resolution of pericardial inflammation 6

Pericardiectomy is indicated for symptomatic patients (NYHA class III-IV) with persistent constriction after conservative therapy or with chronic disease features. 6

• Complete pericardiectomy via midline sternotomy removing both parietal and visceral pericardium is the preferred surgical approach 6
• Operative mortality ranges from 6-12% 6
• Critical pitfall: Do not postpone surgery in appropriate candidates; delayed intervention leads to myocardial atrophy and fibrosis, markedly increasing operative mortality 6

Effusive-Constrictive Pericarditis

Effusive-constrictive pericarditis requires visceral pericardiectomy and should be performed only in high-volume, experienced centers; diagnosis rests on persistent elevation of right atrial pressure after pericardiocentesis. 6

• Management follows the chronic constriction pathway 6

Prognostic Factors

Poor surgical outcomes are predicted by prior mediastinal radiation, worse renal function, higher pulmonary artery systolic pressure, abnormal left ventricular systolic function, lower serum sodium, older age, and Child-Pugh score ≥7. 6

• Pericardial calcification does not impact survival 6
• Risk of progression to constrictive pericarditis varies dramatically by etiology: <1% for viral/idiopathic, 2-5% for immune-mediated and neoplastic, and 20-30% for bacterial (especially purulent) pericarditis 4

Critical Pitfalls to Avoid

• Do not exclude constrictive pericarditis solely on the basis of normal pericardial thickness; 18-20% of confirmed cases have thickness <3 mm 6
• Do not misinterpret ascites, hepatomegaly, or liver dysfunction as primary liver disease without evaluating for constrictive pericarditis 6
• Avoid aggressive use of vasodilators or diuretics in acute presentations before confirming the diagnosis, as they may worsen hemodynamics 6
• Delaying surgery in appropriate candidates leads to disease progression, with medical therapy providing only temporary symptom relief 6